A previous study reviewed 35 studies and found that BRAFV600E mutation occurred in 63.5% (95% CI, 46.98%−78.53%) of CRC patients who exhibited MLH1 methylation or MLH1 loss in Western countries [14]. The gene discussed is MLH1; the disease is colorectal carcinoma.